基因技术工具 · 全部实体（第 97 / 100 页）

本页收录第 9601–9700 条，共 10000 条 · 返回 基因技术工具 首页

• Applications and Explorations of Crispr-Based Genome Editing Tool-Box in Abiotic Stress Tolerance in Plants
  crossref Deepu Pandita 2025-04-01T15:32:44Z 置信度 0.70
• ESDR157 - Comparing adenine base editing and CRISPR-Cas9 gene editing strategies to correct recurrent mutations in RDEB primary fibroblasts
  crossref Adam Sheriff 2021-09-18T12:44:42Z 置信度 0.70
• Genome Editing Tool CRISPR-Cas: Legal and Ethical Considerations for Life Science
  crossref Neelam Pandey, Asha Arora, Ashwani Kumar 2024-03-18T08:02:35Z 置信度 0.70
• Gene Therapy for Duchenne Muscular Dystrophy
  crossref Marisa Wen 2021-10-26T16:40:42Z 置信度 0.70
• The Ethical Concerns of Using CRISPR-CAS9 for Gene Editing in Humans
  crossref Simran Mamik 2023-11-01T04:30:02Z 置信度 0.70
• Legal, Ethical, and Social Issues Remained in CRISPR/Cas Genome Editing Technology
  crossref Sana Ullah 2026-04-01T14:14:25Z 置信度 0.70
• Remote-Controlled Gene Editing: Integrating Electrogenetics with CRISPR for Precision Therapy
  The CRISPR-Cas system has revolutionized gene editing and transcriptional regulation, yet its therapeutic and synthetic potential is limited by a lack of spatiotemporal control. Electrogenetics using electrical signals to modulate gene expression offers a dyna…
  crossref Mohammad Mahboob Kanafi 2025-06-18T12:33:02Z 置信度 0.70
• Gene Editing with CRISPR: A Novel Approach to Type 1 Diabetes Management
  crossref William Luo 2025-10-10T15:23:25Z 置信度 0.70
• CRISPR-Cas Systems in Genetic Diseases
  crossref Zainab Manzoor, Umar Rasool, Arshid Reshi, Aarif Ali 2025-07-04T10:41:22Z 置信度 0.70
• Advances in Delivery of CRISPR–Cas Reagents for Precise Genome Editing in Plants
  crossref Yuan-Yeu Yau, Mona Easterling, Ashwani Kumar 2024-03-18T08:02:35Z 置信度 0.70
• Evolution of Genetic Engineering in Medicine: Recombinant DNA and CRISPR Gene Editing Technologies
  crossref Manasvi Jambula 2023-12-25T18:50:25Z 置信度 0.70
• HIV overcomes CRISPR gene-editing attack
  crossref Ewen Callaway 2016-04-07T14:50:20Z 置信度 0.70
• Review for "Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment"
  crossref 2019-06-25T13:25:55Z 置信度 0.70
• Targeted Gene Editing for PKD: Optimizing CRISPR / Cas9 Delivery Through Electroporation and Lipid Nanoparticles
  crossref Raksheet Reddy Gummakonda 2025-07-05T10:04:27Z 置信度 0.70
• Gene Editing (See Genome Editing; CRISPR)
  crossref Henk ten Have, Maria do Céu Patrão Neves 2021-06-02T18:09:36Z 置信度 0.70
• Gene Editing With TALEN and CRISPR/Cas in Rice
  crossref Honghao Bi, Bing Yang 2017-05-24T16:01:29Z 置信度 0.70
• Advancing CRISPR and Gene Editing Therapies: Are We Close to Treating Usher Syndrome?
  crossref Chian Fan 2026-04-23T06:07:20Z 置信度 0.70
• Genome Editing (See Gene Editing; CRISPR)
  crossref Henk ten Have, Maria do Céu Patrão Neves 2021-06-02T18:09:36Z 置信度 0.70
• CRISPR gene editing: Moving closer to home
  crossref Amber Dance 2024-01-22T23:53:15Z 置信度 0.70
• CRISPR gene editing: Why we need Slow Science
  crossref Landon Getz, Graham Dellaire 2025-08-25T23:59:42Z 置信度 0.70
• CRISPR (See Genomic Editing; Gene Editing)
  crossref Henk ten Have, Maria do Céu Patrão Neves 2021-06-02T18:09:36Z 置信度 0.70
• CRISPR-Click Enables Dual-Gene Editing with Modular Synthetic sgRNAs
  crossref 2022-04-18T17:00:10Z 置信度 0.70
• The CRISPR Revolution: Gene Editing, Biotechnology, and the Future of Humanity
  Abstract: CRISPR-based gene editing has reconfigured the boundary between biological observation and biological design. Its power lies not only in the ability to edit DNA, but in the ability to translate hypotheses about function into interventions that can be…
  crossref Murali Krishna Pasupuleti 2026-01-21T06:31:22Z 置信度 0.70
• Therapeutic Applications of CRISPR-Cas9 Gene Editing
  CRISPR-Cas9 is a gene editing tool used extensively in biological research that is now making its way into clinical therapies. With the first CRISPR therapy obtaining approval by the United States’ Food and Drug Administration (FDA) in late 2023, we look at cl…
  preprints Aditya Bharti, Joann Mudge 2025 置信度 0.74
• Microparticle delivery of CRISPR-Cas9 ribonucleoprotein to Isochrysis galbana for gene editing of URA3 gene. v1
  This is a method for gene editing in Isochrysis galbana. It uses a ribonucleoprotein (RNP) approach to introduce Cas9 into I. galbana for targeted gene editing, with selection for resistance to 5-FOA. The method is promising as we have good evidence that editi…
  crossref Andrea Highfield, Glen Wheeler 2021-06-21T16:46:11Z 置信度 0.70
• The Emerging Impact of CRISPR and Gene Editing on Global Crop Improvement
  Integration of CRISPR with other cutting-edge technologies, such as synthetic biology, artificial intelligence, and high-throughput phenotyping, holds immense promise for accelerating crop improvement efforts. As research continues to refine CRISPR tools and e…
  crossref Mansi, Priyanka Danai 2025-05-31T03:01:06Z 置信度 0.70
• Development of a CRISPR-Cas9-Based Multiplex Genome-Editing Vector and Stay-Green Lettuce
  crossref Takeshi Ito, Hiroshi Yamatani, Takashi Nobusawa, Makoto Kusaba 2024-03-18T08:02:35Z 置信度 0.70
• Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing
  crossref 2020-04-07T08:48:17Z 置信度 0.70
• CRISPR/Cas9 as a Genome Editing Tool for Targeted Gene Integration in CHO Cells
  crossref Daria Sergeeva, Jose Manuel Camacho-Zaragoza, Jae Seong Lee, Helene Faustrup Kildegaard 2019-03-25T09:03:05Z 置信度 0.70
• Development of CXCR4 Gene Editing in Human Umbilical Vein Endothelial Cells Using the CRISPR/CAS9 System
  crossref Sezer Akgöl, Ecren Yetim, Fatih Kocabaş 2021-12-21T14:12:19Z 置信度 0.70
• Cautious Progress Toward Clinical Application of Human Gene Editing
  crossref Sheetal Soni 2020-02-24T11:14:18Z 置信度 0.70
• CRISPR-Cas Based Genome Editing Strategies Towards Adaptation of Rice Crop to Disease Resistance
  crossref Irfan Ullah, Tariq Mahmood 2026-04-01T14:14:25Z 置信度 0.70
• Gene Editing Through CRISPR-Based Technology
  crossref Ziheng Zhang, Ping Wang, Ji-Long Liu 2022-02-21T13:06:56Z 置信度 0.70
• CRISPR/Cas and Gene Therapy: An Overview
  crossref Luis María Vaschetto 2021-12-15T16:42:46Z 置信度 0.70
• CRISPR gene editing produces unwanted DNA deletions
  crossref Heidi Ledford 2018-07-16T15:38:40Z 置信度 0.70
• CRISPR-Cas systems in diagnostics: A comprehensive assessment of Cas effectors and biosensors
  crossref Reha Onur Azizoglu 2022-11-14T02:37:38Z 置信度 0.70
• Revolutionizing gene editing techniques in medicine
  crossref Anata Bezman, Lananh Ho 2025-01-10T18:28:08Z 置信度 0.70
• Crispr-Based In Vivo Gene Editing For Rare And Previously Untreatable Diseases
  crossref Obi Blessing Obi 2026-01-23T14:19:26Z 置信度 0.70
• CRISPR gene-editing system unleashed on RNA
  crossref Karen Weintraub 2016-06-03T13:49:45Z 置信度 0.70
• Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER
  crossref Eva Karina Brinkman, Bas van Steensel 2019-03-25T09:03:05Z 置信度 0.70
• Novel gene-editing technologies: applications of CRISPR-Cas9, base editing, and prime editing in SCID gene therapy
  The use of autologous haematopoietic stem cell gene therapy is increasingly recognised as a promising treatment option for severe combined immunodeficiency diseases (SCID). This approach seeks to correct the underlying genetic cause of SCID conditions, potenti…
  crossref Greg Crawford, Pervinder Sagoo, H. Bobby Gaspar 2026-03-25T06:01:39Z 置信度 0.70
• Applications of RNAi and CRISPR Gene Editing Technologies to Decrease Immunodominant Allergens in Foods
  crossref Asher Boorstein 2024-01-27T20:00:50Z 置信度 0.70
• Review for "Gene Therapy and Gene Editing in Type 1 Diabetes: CRISPR-Based β-Cell Replacement and Treg Immune Modulation Approaches"
  crossref 2026-04-23T21:11:07Z 置信度 0.70
• Application of CRISPR/Cas9-Mediated Gene Editing in Tomato
  crossref Nathan T. Reem, Joyce Van Eck 2019-01-04T17:14:42Z 置信度 0.70
• CRISPR²: A Next-Generation State Dependent Gene Editing System for CRISPR Remission in ME/CFS and Infection Associated Chronic Conditions (Preprint)
  BACKGROUND Chronic multisystem instability remains a central barrier to translating advanced therapeutics, including gene editing, into real-world patient populations. While CRISPR technologies have demonstrated molecular precision in controlled environments, …
  crossref Cynthia Adinig 2026-06-15T13:45:07Z 置信度 0.70
• Specificity of CRISPR‐Cas9 Gene Editing
  crossref Niklas Selfjord, Alexandra Madsen, Pinar Akcakaya 2022-03-18T21:49:17Z 置信度 0.70
• Toward In Vivo Gene Therapy Using CRISPR
  crossref Kristian Alsbjerg Skipper, Jacob Giehm Mikkelsen 2019-03-25T13:03:05Z 置信度 0.70
• What is CRISPR gene editing, and how does it work?
  crossref Merlin AM 2025-08-26T05:30:58Z 置信度 0.70
• The application of CRISPR gene-editing technology in influenza prevention and control.
  europepmc 2026 置信度 0.80
• Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.
  europepmc 2026 置信度 0.80
• From one-size-fits-all to on-demand: personalized crispr gene editing for rare genetic liver diseases.
  europepmc 2026 置信度 0.80
• Decoding the role of chromatin context in the off-target effects of CRISPR gene editing with EGOLD.
  europepmc 2026 置信度 0.80
• CRISPR Gene Editing for Nucleotide Repeat Expansion Disorders: A Systematic Review of Preclinical and Clinical Evidence.
  europepmc 2026 置信度 0.80
• CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia.
  europepmc 2026 置信度 0.80
• The potential and innovative applications of CRISPR gene editing technology in enzyme gene development.
  europepmc 2026 置信度 0.80
• Integrative Multiomic Analysis Reveals How Non-Viral Delivery System Selection Shapes CRISPR Gene Editing Outcomes in Stem Cells
  europepmc 2026 置信度 0.80
• CRISPR gene editing of AtRING1 unravels a critical role of RAWUL domain in PRC1 repression of transcription.
  europepmc 2026 置信度 0.80
• nf-core/crisprseq: a versatile pipeline for comprehensive analysis of CRISPR gene editing and screening assays.
  europepmc 2026 置信度 0.80
• Female iPSC X-chromosome inactivation (XCI) erosion and its transcriptomic effects during CRISPR gene editing and neural differentiation
  europepmc 2026 置信度 0.80
• Artificial Intelligence-Assisted CRISPR Gene Editing: Current Advances, Clinical Challenges, and Future Directions in Precision Medicine.
  europepmc 2026 置信度 0.80
• Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components.
  europepmc 2026 置信度 0.80
• LeDNA: a cut-and-build toolkit to democratize CRISPR gene editing technology education.
  europepmc 2025 置信度 0.80
• Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer's and Parkinson's disease.
  europepmc 2025 置信度 0.80
• Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine.
  europepmc 2025 置信度 0.80
• Vectors in CRISPR Gene Editing for Neurological Disorders: Challenges and Opportunities.
  europepmc 2025 置信度 0.80
• CRISPR Gene-Editing Combat: Targeting AIDS for total eradication.
  europepmc 2024 置信度 0.80
• Biomimetic Composite Nanoparticles with Immune Modulation and CRISPR Gene Editing for Enhancing Mild Photothermal Therapy-Based Synergistic Antitumor Therapy.
  europepmc 2025 置信度 0.80
• Research advances CRISPR gene editing technology generated models in the study of epithelial ovarian carcinoma.
  europepmc 2025 置信度 0.80
• Correction to 'AlPaCas: allele-specific CRISPR gene editing through a protospacer-adjacent-motif (PAM) approach'.
  europepmc 2024-12-20T10:35:08Z 置信度 0.80
• Rictor CRISPR Gene Editing by Lipid Nanoparticle Delivery Stimulates Anti-tumor Immunity in Breast Cancer Liver Metastasis Model
  europepmc 2025 置信度 0.80
• LeDNA: a cut-and-build toolkit to democratize education on CRISPR gene editing technology
  europepmc 2024 置信度 0.80
• Versatile Cell Penetrating Peptide for Multimodal CRISPR Gene Editing in Primary Stem Cells
  europepmc 2024 置信度 0.80
• DIPA-CRISPR Gene Editing: A Review Exploring New Horizons in Disease Management
  DIPA-CRISPR is a revolutionary gene editing technology that has set new benchmarks in precision and efficacy. It builds upon the CRISPR-Cas9 system, introducing unparalleled specificity and minimizing unintended effects. Its potential applications in addressin…
  europepmc Abhijay Shah, Dev Desai, Hetvi Shah 2024 置信度 0.80
• Leveraging CRISPR gene editing technology to optimize the efficacy, safety and accessibility of CAR T-cell therapy.
  europepmc 2024 置信度 0.80
• How CRISPR gene editing could help treat Alzheimer's.
  europepmc Tosin Thompson 2023-12-11T20:05:01Z 置信度 0.80
• Generation of a PARPi-sensitive homozygous BRCA1-methylated OVCAR8 cell line using targeted CRISPR gene editing
  europepmc 2024 置信度 0.80
• In vivo CRISPR gene editing in patients with herpetic stromal keratitis.
  europepmc 2023 置信度 0.80
• CRISPR Gene Editing of a Virulent Bacteriophage.
  Genome editing by site-directed mutagenesis is an important tool in biological research. CRISPR gene editing is the latest such tool developed, and one that is widely applicable to study organisms from all kingdoms of life. Here, I introduce a method for makin…
  europepmc Andrew Camilli 2023 置信度 0.80
• AlPaCas: allele-specific CRISPR gene editing through a protospacer-adjacent-motif (PAM) approach.
  europepmc 2024 置信度 0.80
• CRISPR gene-editing therapies for hypertrophic cardiomyopathy.
  europepmc 2023 置信度 0.80
• CRISPR gene editing to improve crop resistance to parasitic plants.
  europepmc 2023 置信度 0.80
• Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein
  europepmc 2023 置信度 0.80
• Direct parental CRISPR gene editing in the predatory bug Orius strigicollis, a biocontrol agent against small arthropods.
  europepmc 2024 置信度 0.80
• Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy.
  europepmc Emily Harris 2024 置信度 0.80
• An LNP-CRISPR gene editing drug demonstrates efficacy and safety in patients with hereditary angioedema following in vivo administration.
  europepmc 2024 置信度 0.80
• CRISPR Gene Editing of Virulent Bacteriophage ICP1.
  Tools for site-directed mutagenesis of virulent bacteriophages (phages; viruses of bacteria) have traditionally lagged those for bacteria, hindering their study. CRISPR gene editing represents a new and highly efficient method for editing virulent phage genome…
  europepmc Andrew Camilli 2023 置信度 0.80
• Electroporation-based CRISPR gene editing in adult buffalo fibroblast cells.
  europepmc 2023 置信度 0.80
• Should we use CRISPR gene editing in human embryos?
  europepmc 2023 置信度 0.80
• Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics.
  europepmc 2023 置信度 0.80
• Cyclization-enhanced poly(β-amino ester)s vectors for efficient CRISPR gene editing therapy.
  europepmc 2024 置信度 0.80
• CRISPR Gene Editing of Hematopoietic Stem and Progenitor Cells.
  europepmc 2023 置信度 0.80
• In Vivo CRISPR Gene Editing in Patients with Herpes Stromal Keratitis
  europepmc 2023 置信度 0.80
• Vector enabled CRISPR gene editing - A revolutionary strategy for targeting the diversity of brain pathologies.
  europepmc 2023 置信度 0.80
• [Research advances in photoactivatable CRISPR gene editing technology].
  europepmc 2022 置信度 0.80
• The future of CRISPR gene editing according to plant scientists.
  europepmc 2022 置信度 0.80
• The gene therapy for corneal pathology with novel nonsense cystinosis mouse lines created by CRISPR Gene Editing.
  europepmc 2023 置信度 0.80
• Disrupting Protein Expression with Double-Clicked sgRNA-Cas9 Complexes: A Modular Approach to CRISPR Gene Editing.
  europepmc 2023 置信度 0.80
• Magnetogenetics with Piezo1 Mechanosensitive Ion Channel for CRISPR Gene Editing.
  europepmc 2022 置信度 0.80
• A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing.
  europepmc 2023 置信度 0.80
• Chemical Control of CRISPR Gene Editing via Conditional Diacylation Crosslinking of Guide RNAs.
  europepmc 2023 置信度 0.80